Literature DB >> 22711893

Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection.

Jared H Rowe1, James M Ertelt, Sing Sing Way.   

Abstract

Although best characterized for sustaining T cell exhaustion during persistent viral infection, programmed death ligand-1 (PDL-1) also stimulates the expansion of protective T cells after infection with intracellular bacterial pathogens. Therefore, establishing the molecular signals that control whether PDL-1 stimulates immune suppression or activation is important as immune modulation therapies based on manipulating PDL-1 are being developed. In this study, the requirement for PDL-1 blockade initiated before infection with the intracellular bacterium Listeria monocytogenes in reducing pathogen-specific T cell expansion is demonstrated. In turn, the role of proinflammatory cytokines triggered early after L. monocytogenes infection in controlling PDL-1-mediated T cell stimulation was investigated using mice with targeted defects in specific cytokines or cytokine receptors. These experiments illustrate an essential role for IL-12 or type I IFNs in PDL-1-mediated expansion of pathogen-specific CD8(+) T cells. Unexpectedly, direct stimulation by neither IL-12 nor type I IFNs on pathogen-specific CD8(+) cells was essential for PDL-1-mediated expansion. Instead, the absence of early innate IFN-γ production in mice with combined defects in both IL-12 and type I IFNR negated the impacts of PDL-1 blockade. In turn, IFN-γ ablation using neutralizing Abs or in mice with targeted defects in IFN-γR each eliminated the PDL-1-mediated stimulatory impacts on pathogen-specific T cell expansion. Thus, innate IFN-γ is essential for PDL-1-mediated T cell stimulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711893      PMCID: PMC3402342          DOI: 10.4049/jimmunol.1103227

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

Review 1.  Inflammatory cytokines as a third signal for T cell activation.

Authors:  Julie M Curtsinger; Matthew F Mescher
Journal:  Curr Opin Immunol       Date:  2010-04-02       Impact factor: 7.486

2.  IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation.

Authors:  Ozen Sercan; Diana Stoycheva; Günter J Hämmerling; Bernd Arnold; Thomas Schüler
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

3.  Programming for CD8 T cell memory development requires IL-12 or type I IFN.

Authors:  Zhengguo Xiao; Kerry A Casey; Stephen C Jameson; Julie M Curtsinger; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection.

Authors:  Su-Kil Seo; Hye-Young Jeong; Sae-Gwang Park; Soo-Woong Lee; Il-Whan Choi; Lieping Chen; Inhak Choi
Journal:  Immunology       Date:  2007-10-25       Impact factor: 7.397

5.  PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes.

Authors:  Jared H Rowe; Tanner M Johanns; James M Ertelt; Sing Sing Way
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

Authors:  Monique Lafon; Françoise Mégret; Sven G Meuth; Ole Simon; Myriam L Velandia Romero; Mireille Lafage; Lieping Chen; Lena Alexopoulou; Richard A Flavell; Christophe Prehaud; Heinz Wiendl
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

7.  PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.

Authors:  Adriano Boasso; Andrew W Hardy; Alan L Landay; Jeffrey L Martinson; Stephanie A Anderson; Matthew J Dolan; Mario Clerici; Gene M Shearer
Journal:  Clin Immunol       Date:  2008-07-22       Impact factor: 3.969

8.  Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells.

Authors:  Nural N Orgun; Meredith A Mathis; Christopher B Wilson; Sing Sing Way
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

9.  Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo.

Authors:  Daisuke Kamimura; Michael J Bevan
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

10.  Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection.

Authors:  Sang-Jun Ha; Scott N Mueller; E John Wherry; Daniel L Barber; Rachael D Aubert; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

View more
  9 in total

1.  Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.

Authors:  Tatiana M Garcia-Bates; Mariana L Palma; Chengli Shen; Andrea Gambotto; Bernard J C Macatangay; Robert L Ferris; Charles R Rinaldo; Robbie B Mailliard
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

2.  Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status.

Authors:  Sara Corvigno; Jared K Burks; Wei Hu; Yanping Zhong; Nicholas B Jennings; Nicole D Fleming; Shannon N Westin; Bryan Fellman; Jinsong Liu; Anil K Sood
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-02       Impact factor: 4.322

3.  The role of programmed death ligand 1 pathway in persistent biomaterial-associated infections.

Authors:  Agnieszka Magryś; Jolanta Paluch-Oleś; Agnieszka Bogut; Michał Kiełbus; Dorota Plewik; Maria Kozioł-Montewka
Journal:  J Microbiol       Date:  2015-07-31       Impact factor: 3.422

4.  Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions.

Authors:  Michael B Bernstein; Charlie T Garnett; Huogang Zhang; Anna Velcich; Max M Wattenberg; Sofia R Gameiro; Shalom Kalnicki; James W Hodge; Chandan Guha
Journal:  Cancer Biother Radiopharm       Date:  2014-04-02       Impact factor: 3.099

5.  Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.

Authors:  Kyle K Payne; Rebecca C Keim; Laura Graham; Michael O Idowu; Wen Wan; Xiang-Yang Wang; Amir A Toor; Harry D Bear; Masoud H Manjili
Journal:  J Leukoc Biol       Date:  2016-02-29       Impact factor: 4.962

6.  CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

Authors:  Yu Zhu; Brett L Knolhoff; Melissa A Meyer; Timothy M Nywening; Brian L West; Jingqin Luo; Andrea Wang-Gillam; S Peter Goedegebuure; David C Linehan; David G DeNardo
Journal:  Cancer Res       Date:  2014-07-31       Impact factor: 12.701

7.  A potential new pathway for PD-L1 costimulation of the CD8-T cell response to Listeria monocytogenes infection.

Authors:  Daqi Xu; Han-Hsuan Fu; Joshua J Obar; Jang-June Park; Koji Tamada; Hideo Yagita; Leo Lefrançois
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

8.  Activation of IFN-γ/STAT/IRF-1 in hepatic responses to Klebsiella pneumoniae infection.

Authors:  Yi-Chun Lin; Min-Chi Lu; Chingju Lin; Ming-Ko Chiang; Ming-Shiou Jan; Hui-Ling Tang; Hsu-Chung Liu; Wea-Lung Lin; Chih-Yang Huang; Chuan-Mu Chen; Yi-Chyi Lai
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

Review 9.  The risks of targeting co-inhibitory pathways to modulate pathogen-directed T cell responses.

Authors:  Helge Frebel; Annette Oxenius
Journal:  Trends Immunol       Date:  2013-01-16       Impact factor: 16.687

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.